Latin America and Caribbean should expand vaccine production, PAHO suggests

Latin America and Caribbean should expand vaccine production, PAHO suggests

Dr Etienne: Low regional percentage of vaccinated a “symptom” of overdependence on imports

Bahamas, Haiti and Trinidad and Tobago saw COVID deaths double in the last week

WASHINGTON, DC — Pan American Health Organization (PAHO) Director Carissa F Etienne yesterday called for closing “glaring gaps” in access to COVID-19 vaccines in Latin America and the Caribbean by relying less on imports and more on expanded regional production of medical products, including vaccines.

Pointing out that only three percent of people in Latin America and the Caribbean have been fully vaccinated against COVID-19, Etienne asserted that the shortage of vaccines is a “symptom of our region’s overdependence on imports for essential medical supplies”.

“Less than four percent of medical products in use during the COVID response have come from the region,” she told journalists at her weekly media briefing yesterday.

Pan American Health Organization (PAHO) Director Dr Carissa Etienne.

“Expanding our regional capacity to manufacture strategic medical supplies — especially vaccines — is a must, both for our people and as a matter of health security.”

Etienne drew attention to the region’s “building blocks” for expanded production — strong academic and research institutions; manufacturing capacity and regulatory systems; and an effective procurement mechanism. Argentina, Brazil, Cuba and Mexico have well-established vaccine-manufacturing facilities, some of which are being updated to produce COVID-19 vaccines, she said.

“We must ramp up production for the entire vaccine value chain — from the ingredients that go into vaccines to the vials and syringes that help us deliver them — without compromising quality,” she said.

Etienne added that the region must “embrace the promise of mRNA technologies”, which are the basis of the highly effective Moderna and Pfizer vaccines but could also be used for other vaccines.

She said: “PAHO is working closely with the World Health Organization (WHO) on its COVID-19 mRNA vaccine technology transfer hub.”

PAHO also is in discussion with regional partners such as the Inter-American Development Bank (IDB), the Organization of American States (OAS) and its member states to ensure countries interested in expanding manufacturing have resources and support, she said. Argentina, Chile and Peru are among those that have already shown interest.

“For this to work,” Etienne said, “we need scale, a commitment to purchase regionally-made products and assurance that products will flow freely and without export bans — even during emergencies.

“Our Revolving Fund stands ready to help purchase and deliver these products throughout our region — as we’ve done for the last 40 years.”

A man receives a jab of the COVID-19 vaccine at the RBDF Base on Monday, March 22, 2021. (RBDF PHOTO)

“A regional manufacturing network that builds on our national strengths and that is backed by sustained financial commitments is long overdue. It’s also our best hope for a long-term solution, because COVID will not be the last virus that tests our health systems.”

PAHO has delivered more than 12 million COVAX-procured vaccine doses to countries in Latin America and the Caribbean. Another 770,000 doses are on the way to Central American and Caribbean countries, Etienne said.

She also addressed the pandemic’s heavy toll, noting there were over 1.2 million new COVID-19 cases in the Americas in the past week and about 31,000 deaths.

Although COVID-19 infections generally have declined in the past month in the region, new cases and deaths are still on the rise in many countries, Etienne said.

Many Caribbean countries — including The Bahamas, Haiti and Trinidad and Tobago — have seen COVID-19 deaths double in the last week.

Pandemic conditions have changed profoundly in the United States, “where widespread [vaccine] coverage has led to a sharp reduction in US COVID infections, deaths and hospitalizations”, Etienne noted.

“The progress we’re seeing in the US is a testament to the power of safe and effective COVID vaccines, but it underscores the vital importance of accelerating access to vaccines throughout our region, so that other countries can fully immunize their populations,” she emphasized.

“We urgently need more vaccines for Latin America and the Caribbean, a region that has been put to the test by this pandemic.”